T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
MSCI
MSCI
$40.9B
| $218M | 0.03% |
452,049
-129,509
| -22% | -$64.3M |
|
402
Illinois Tool Works
ITW
$83.3B
| $218M | 0.03% |
918,929
+56,168
| +7% | +$13.9M |
|
403
Motorola Solutions
MSI
$77.7B
| $218M | 0.03% |
563,498
+127,655
| +29% | +$46.1M |
|
404
East-West Bancorp
EWBC
$18.5B
| $217M | 0.03% |
2,962,240
-1,006,991
| -25% | -$74.7M |
|
405
Phillips 66
PSX
$90B
| $217M | 0.03% |
1,534,776
-1,328,827
| -46% | -$197M |
|
406
Aon
AON
$74.7B
| $215M | 0.03% |
731,517
+73,108
| +11% | +$21.6M |
|
407
Verra Mobility
VRRM
$714M
| $213M | 0.03% |
7,812,581
+385,054
| +5% | +$9.93M |
|
408
Newmont
NEM
$124B
| $212M | 0.03% |
5,074,668
+167,567
| +3% | +$6.85M |
|
409
Expro Ltd
XPRO
$2.07B
| $209M | 0.03% |
9,116,737
+1,285,787
| +16% | +$26.6M |
|
410
Cardinal Health
CAH
$54.5B
| $208M | 0.02% |
2,120,402
-610,452
| -22% | -$62.2M |
|
411
Packaging Corp of America
PKG
$22.8B
| $207M | 0.02% |
1,134,216
+264,875
| +30% | +$48.2M |
|
412
Kohl's
KSS
$2.19B
| $206M | 0.02% |
8,952,548
-90,825
| -1% | -$2.19M |
|
413
Amcor
AMCR
$21.5B
| $203M | 0.02% |
4,158,443
+37,611
| +0.9% | +$1.82M |
|
414
Morningstar
MORN
$7.41B
| $203M | 0.02% |
684,740
-3
| -0% | -$888 |
|
415
Revolution Medicines
RVMD
$44B
| $202M | 0.02% |
5,216,659
+402,349
| +8% | +$15M |
|
416
Seadrill
SDRL
$2.92B
| $202M | 0.02% |
3,920,356
-702,952
| -15% | -$35.6M |
|
417
Cboe Global Markets
CBOE
$30.4B
| $200M | 0.02% |
1,176,415
+457,595
| +64% | +$81.3M |
|
418
Ero Copper
ERO
$3.76B
| $199M | 0.02% |
9,319,728
+211,023
| +2% | +$4.43M |
|
419
Crinetics Pharmaceuticals
CRNX
$8.96B
| $197M | 0.02% |
4,406,456
+583,238
| +15% | +$26.9M |
|
420
Gilead Sciences
GILD
$168B
| $195M | 0.02% |
2,845,428
+352,914
| +14% | +$23.6M |
|
421
Gen Digital
GEN
$17.1B
| $195M | 0.02% |
7,813,579
+14,661
| +0.2% | +$335K |
|
422
Blackstone
BX
$110B
| $194M | 0.02% |
1,564,572
+219,567
| +16% | +$27M |
|
423
Equinor
EQNR
$97.3B
| $193M | 0.02% |
6,771,075
-12,263
| -0.2% | -$342K |
|
424
SBA Communications
SBAC
$19.4B
| $192M | 0.02% |
976,603
-9,884
| -1% | -$1.96M |
|
425
Kymera Therapeutics
KYMR
$9.48B
| $191M | 0.02% |
6,390,658
+58,646
| +0.9% | +$2.03M |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.